FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy

Macrophages contribute to tumour progression and response to therapy. Here, the authors show that absence of FGF2 in the tumour microenvironment reduces tumour growth and enhances the anti-tumour immune response by altering macrophage polarization. As a result, disruption of this macrophage programm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jae Hong Im, Jon N. Buzzelli, Keaton Jones, Fanny Franchini, Alex Gordon-Weeks, Bostjan Markelc, Jianzhou Chen, Jin Kim, Yunhong Cao, Ruth J. Muschel
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/aac2c94a42384be185bf6c4fce5f6dff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aac2c94a42384be185bf6c4fce5f6dff
record_format dspace
spelling oai:doaj.org-article:aac2c94a42384be185bf6c4fce5f6dff2021-12-02T16:28:52ZFGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy10.1038/s41467-020-17914-x2041-1723https://doaj.org/article/aac2c94a42384be185bf6c4fce5f6dff2020-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-17914-xhttps://doaj.org/toc/2041-1723Macrophages contribute to tumour progression and response to therapy. Here, the authors show that absence of FGF2 in the tumour microenvironment reduces tumour growth and enhances the anti-tumour immune response by altering macrophage polarization. As a result, disruption of this macrophage programming by anti-FGF2 blocking antibodies enhances the outcome from radiotherapy. Jae Hong ImJon N. BuzzelliKeaton JonesFanny FranchiniAlex Gordon-WeeksBostjan MarkelcJianzhou ChenJin KimYunhong CaoRuth J. MuschelNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Jae Hong Im
Jon N. Buzzelli
Keaton Jones
Fanny Franchini
Alex Gordon-Weeks
Bostjan Markelc
Jianzhou Chen
Jin Kim
Yunhong Cao
Ruth J. Muschel
FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
description Macrophages contribute to tumour progression and response to therapy. Here, the authors show that absence of FGF2 in the tumour microenvironment reduces tumour growth and enhances the anti-tumour immune response by altering macrophage polarization. As a result, disruption of this macrophage programming by anti-FGF2 blocking antibodies enhances the outcome from radiotherapy. 
format article
author Jae Hong Im
Jon N. Buzzelli
Keaton Jones
Fanny Franchini
Alex Gordon-Weeks
Bostjan Markelc
Jianzhou Chen
Jin Kim
Yunhong Cao
Ruth J. Muschel
author_facet Jae Hong Im
Jon N. Buzzelli
Keaton Jones
Fanny Franchini
Alex Gordon-Weeks
Bostjan Markelc
Jianzhou Chen
Jin Kim
Yunhong Cao
Ruth J. Muschel
author_sort Jae Hong Im
title FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
title_short FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
title_full FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
title_fullStr FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
title_full_unstemmed FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
title_sort fgf2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/aac2c94a42384be185bf6c4fce5f6dff
work_keys_str_mv AT jaehongim fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT jonnbuzzelli fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT keatonjones fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT fannyfranchini fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT alexgordonweeks fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT bostjanmarkelc fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT jianzhouchen fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT jinkim fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT yunhongcao fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT ruthjmuschel fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
_version_ 1718383949046087680